Full Text (PDF)
Original Article

Pain Management in Oral Sub-Mucosal Fibrosis (OSMF) with Alternanthera sessilis (Matsyaakshi): An Adjuvant Therapy

Sangeetha M. Kanna , Sangeetha M. Kanna , S.K. Hiremath

Author Information

Licence:




Indian Journal of Ancient Medicine and Yoga 6(4):p 157-164, October-December 2013. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Oral cavity is a major entrance for bodily entities. It has a high risk of getting infections, irritations, etc. Oral Submucosal Fibrosis (OSMF) is an Oral submucous fibrosis is a chronic debilitating disease of the oral cavity characterized by inflammation and progressive fibrosis of the submucosal tissues. This is called a disease of Indians. Because, it is most predominantly found in Indians and Indians living abroad. Exact etiology is unknown. The pathogenesis of the disease is not well established, believed to be multifactorial. No definite cure and management is available for OSMF. Only symptomatic relieving measures should be done. Use of topical anesthetics and analgesics alters the taste perception thus, impairs digestion and subsequent processes. Matsyaakshi is a drug with traditional values, available in all the seasons, throughout the India. It is rich in antioxidant betacarotene, Vitamin C and other essential chemicals. It is a traditional drug of choice for controlling the pain in oral cavity. This controls the pain in oral cavity rather than altering the taste perception and thus, does not interfere with the digestion. 

 

Keywords: OSMF (Oral Submucosal Fibrosis); Matsyaakshi; Anaesthesia.  


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Monday 13 July 2026, 18:59:14 (IST)


2256

Accesses

3
632
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share